EVALUATING DIFFERENCES IN THE ENROLLED POPULATIONS OF RANDOMIZED CLINICAL TRIALS OF SYSTEMIC LUPUS ERYTHEMATOSUS

被引：0
|
作者：
Goel, N. [1 ,2 ]
Barrett, B. [3 ]
Duncan, A. [4 ]
Gallagher, M. -B. [1 ]
Mackey, M. [3 ]
机构：
[1] Quintiles Inc, Durham, NC USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] Quintiles Inc, Rockville, MD USA
[4] Quintiles Inc, Reading, Berks, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4457
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0346
引用
收藏
页码：560 / 560
页数：1
相关论文
共 50 条
  • [41] The Impact of Tabalumab on the Kidney in Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized Clinical Trials
    Dooley, Mary Anne
    Rovin, Brad H.
    Radhakrishnan, Jai
    Ginzler, Ellen M.
    Forrester, Tammy
    Anderson, Pamela
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [42] The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials
    Rovin, B. H.
    Dooley, M. A.
    Radhakrishnan, J.
    Ginzler, E. M.
    Forrester, T. D.
    Anderson, P. W.
    LUPUS, 2016, 25 (14) : 1597 - 1601
  • [43] Systemic lupus erythematosus trials: successes and issues
    Ginzler, EM
    Moldovan, I
    CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (05) : 499 - 504
  • [44] Evaluating the Construct of Damage in Systemic Lupus Erythematosus
    Johnson, Sindhu R.
    Gladman, Dafna D.
    Brunner, Hermine, I
    Isenberg, David
    Clarke, Ann E.
    Barber, Megan R. W.
    Arnaud, Laurent
    Fortin, Paul R.
    Mosca, Marta
    Voskuyl, Alexandre E.
    Manzi, Susan
    Aranow, Cynthia
    Askanase, Anca
    Alarcon, Graciela S.
    Bae, Sang-Cheol
    Costedoat-Chalumeau, Nathalie
    English, Jessica A.
    Pons-Estel, Guillermo J.
    Pons-Estel, Bernardo A.
    Gilman, Rebecca
    Ginzler, Ellen M.
    Hanly, John G.
    Jacobsen, Soren
    Kalunian, Kenneth
    Kamen, Diane L.
    Lambalgen, Chynace
    Legge, Alexandra
    Lim, S. Sam
    Mak, Anselm
    Morand, Eric F.
    Peschken, Christine A.
    Petri, Michelle
    Rahman, Anisur
    Ramsey-Goldman, Rosalind
    Reynolds, John A.
    Romero-Diaz, Juanita
    Ruiz-Irastorza, Guillermo
    Sanchez-Guerrero, Jorge
    Svenungsson, Elisabet
    Touma, Zahi
    Urowitz, Murray
    Vinet, Evelyne
    van Vollenhoven, Ronald F.
    Waldhauser, Heather
    Wallace, Daniel J.
    Zoma, Asad
    Bruce, Ian N.
    ARTHRITIS CARE & RESEARCH, 2023, 75 (05) : 998 - 1006
  • [45] Assessing recruitment and retention strategies in clinical trials for inequitable populations in systemic lupus erythematosus: A cross-sectional analysis
    Rowsey, Kaylyn
    Sims, Seth
    Ghebrehiwet, Merhawit
    Wilson, Andrew
    Autaubo, Josh
    Clark, Payton
    Demla, Simran
    Ford, Alicia Ito
    Vassar, Matt
    AUTOIMMUNITY REVIEWS, 2024, 23 (11)
  • [46] Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials
    Mikdashi, J.
    Esdaile, J. M.
    Alarcon, G. S.
    Crofford, L.
    Fessler, B. J.
    Shanberg, L.
    Brunner, H.
    Gall, V.
    Kalden, J. R.
    Lockshin, M. D.
    Liang, M. H.
    Roberts, N., Jr.
    Schneider, M.
    LUPUS, 2007, 16 (06) : 418 - 425
  • [47] Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus
    Mukhtyar, Chetan
    Boumpas, Dimitrios
    Gordon, Caroline
    Gross, Wolfgang
    Jayne, David
    Luqmani, Raashid
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (05) : 569 - 570
  • [48] Population pharmacokinetics of atacicept in systemic lupus erythematosus: An analysis of three clinical trials
    Pitsiu, Maria
    Yalkinoglu, Oezkan
    Farrell, Colm
    Girard, Pascal
    Vazquez-Mateo, Cristina
    Papasouliotis, Orestis
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (08): : 1157 - 1169
  • [49] The importance of developing reproducible primary endpoints for clinical trials in systemic lupus erythematosus
    Bingyi Yang
    Yiran Chen
    Jiao Jiang
    Christopher Chang
    Haijing Wu
    M. Eric Gershwin
    Qianjin Lu
    Clinical Rheumatology, 2025, 44 (1) : 183 - 192
  • [50] Classification of Patients with Systemic Lupus Erythematosus Enrolled in 2 Phase 3 Trials by EULAR/ACR 2019 Criteria
    Aringer, Martin
    Bruce, Ian N.
    Furie, Richard
    Morand, Eric
    Maho, Emmanuelle
    Lindholm, Catharina
    Tummala, Raj
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3611 - 3613
12345